In addition Bridge-BSR will promote mentoring and bench marking between the clusters in ScanBalt BioRegion. Partners of the project consortium besides ScanBalt are Steinbeis, BioCon Valley, Institute of Fundamental Technological Research in Warsaw, BioForum Oulu, Medicon Valley Alliance, Latvian Biotechnology Association and Estonian Biotech Association.
Joint Innvation Agenda
A key outcome of Bridge-BSR will be a joint innovation agenda for ScanBalt BioRegion targeting SME based innovation. The agenda is to be integrated with regional authorities and their strategies.
The coordinator of the project, General Secretary Peter Frank ScanBalt, says:
“Agreements between the regions on cross-border efforts to strengthen SME based innovation is a significant step to mature ScanBalt BioRegion as a globally competitive hot spot attracting human, industrial and financial resources. The development of shared services between clusters, the common bench mark system to be implemented, enhanced access to financing and integration of intellectual property management in various networks will strongly support this".
On Top of Europe with Ambitions for More
Hans-Robert Metelmann, Professor at Greifswald University, Chairman of ScanBalt, adds:
“The Bridge-BSR will promote cohesion in the Baltic Sea Region between fast growing tiger economies in the Baltic Countries, Poland and Russia, the Nordic Countries already among the most innovative in the World and a Germany going through a very positive development. The Baltic Sea Region is on Top of Europe but has ambitions for more. In the future we will see stronger collaboration on common challenges for the populations in the region. Like for example cancer prevention, where coordinated efforts between policy, science and industry in the Baltic Sea Region can enhance life expectancy".
Official kick-off meeting for Bridge-BSR takes place 6 March 2008 in Riga hosted by the Latvian Biotechnology Association.
ScanBalt BioRegion is composed of Life Science and biotechnology actors in the Nordic countries, Balticum, Poland, Northern part of Germany and North western Russia. The ScanBalt BioRegion have 11 countries and 85 million people, more than 60 universities and 2149 life science/biotech companies including 671 research based biotech SME´s.